Genital Warts (Condylomata Acuminata) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Genital Warts (Condylomata Acuminata) – Drugs In Development, 2024 report and make more profitable business decisions.
Genital warts (condyloma acuminatum) are a sexually transmitted infection caused by the human papillomavirus (HPV) types 6 and 11. It is spread by skin-to-skin contact, usually during sex. The warts present in clusters or separately and can be found in the genital or anal area. Genital warts are typically painless but can cause itching, discomfort, or bleeding. Treatments may include topical medications, cryotherapy (freezing), laser therapy, or surgical removal. Vaccination against certain HPV strains is available and recommended for preventing genital warts and related complications, including cervical cancer in women. Safe sexual practices and regular screenings are essential for prevention and early detection.
The Genital Warts (Condylomata Acuminata) drugs in development market research report provide comprehensive information on the therapeutics under development for Genital Warts (Condylomata Acuminata), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Genital Warts (Condylomata Acuminata) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Genital Warts (Condylomata Acuminata) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 24 molecules, with 21 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Genital Warts (Condylomata Acuminata) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Genital Warts (Condylomata Acuminata) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Genital Warts (Condylomata Acuminata) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Anison Therapeutics OyBeijing Health Guard Biotechnology Inc
Center for Genetic Engineering and Biotechnology
Changchun Institute of Biological Products Co Ltd
Chengdu Institute of Biological Products Co Ltd
Douglas Pharmaceuticals Ltd
Etna Biotech Srl
G&E Herbal Biotechnology Co.
Ltd.
Genetic Immunity Inc
Guangzhou Cape Biological Technology Co Ltd
Jilin University
KinoPharma Inc
Laboratories Ojer Pharma SL
Novan Inc
Orgenesis Inc
Peritech Pharma
Shanghai Bovax Biotechnology Co Ltd
Shanghai Zerun Biotechnology Co Ltd
Shenzhen Second People's Hospital
SinoCelltech Group Ltd
Verrica Pharmaceuticals Inc
Xiamen Innovax Biotech Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Genital Warts (Condylomata Acuminata) reports